Abiopharma

Sable Resumes Oil Flow as Ordered by the Federal DPA with Expected Gross Oil Rate of 50,000 Bbls/d and Expects First Sales by April 1, 2026

Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia

Forgent Reports Second Quarter 2026 Results, Accelerating Order Growth and Issues Fiscal 2026 Guidance

Dollar Tree, Inc. Reports Fourth Quarter and Full Year 2025 Results

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

Nova Winter Freight Haul Underway

“One Battle After Another” Wins USA TODAY’s Movie Meter Competition

PulteGroup Nominates Ben Schall for Election to Board of Directors

Innovative Industrial Properties Announces PharmaCann Resolution and Provides Portfolio Update

New Form S-8 POS - Quipt Home Medical Corp. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001104659-26-028140 <b>Size:</b> 21 KB

New Form S-8 POS - Quipt Home Medical Corp. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001104659-26-028138 <b>Size:</b> 21 KB

New Form F-10POS - Quipt Home Medical Corp. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001104659-26-028135 <b>Size:</b> 32 KB

New Form S-3 - Coya Therapeutics, Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001193125-26-107413 <b>Size:</b> 429 KB

Director Williams Gregg 🟢 acquired 1.6M shares of Vivani Medical, Inc. (VANI) at $1.26 ($1.7M) Transaction Date: Mar 15, 2026 | Filing ID: 000475

Riverstone Holdings Limited - Announcement